Amgen and Merck are currently competing against each other in the market for investor capital.

The entities involved

• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• Merck →

  public company in Indonesia

  • Eli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Sat 17:22
  • Merck will share clinical trial results at the American Academy of Ophthalmology (AAO) meeting.Fri 18:13

Related events

• Both Amdocs and Amgen are currently subject to analyst reviews.Sep 16
• Amgen Inc. trades on the NASDAQ stock exchange.Jun 7
• GSK and Amgen are major biopharma players.Sep 8
• Both Microsoft and Amgen are major dividend payers currently under market scrutiny.Aug 11
• Amgen and Deloitte are cited as examples of companies undergoing industry transformation.Sep 23